Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The immune system is an assembly of structures and processes inside the body to protect against possibly damaging foreign bodies and diseases. It identifies various threats like bacteria, viruses, and parasites and distinguishes them from body's healthy tissues. When the immune system weakness and lose the capability to detect and destroy the abnormal cells or body attacks and damages its tissues lead to diseases like cancer and autoimmune diseases. Immunotherapy is a process which includes the treatment by inducing, enhancing or suppressing an immune system to fight against the diseases.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Immunology Drug market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Immunology Drug market. Detailed analysis of key players, along with key growth strategies adopted by Immunology Drug industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Eli Lilly and Company
Active Biotech
Abbott Laboratories
Bayer AG
GlaxoSmithKline plc
Genentech
Pfizer
Seattle Genetics
By Type:
Monoclonal Antibodies (mAb)
Antibody Drug Conjugates
Interferon and Cytokine therapies
Immunosuppressive medication
By End-User:
Hospitals
Clinics
Cancer Research Centers and Institutes
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Immunology Drug Market
-
1.3 Market Segment by Type
-
1.3.1 USA Immunology Drug Market Size and Growth Rate of Monoclonal Antibodies (mAb) from 2016 to 2027
-
1.3.2 USA Immunology Drug Market Size and Growth Rate of Antibody Drug Conjugates from 2016 to 2027
-
1.3.3 USA Immunology Drug Market Size and Growth Rate of Interferon and Cytokine therapies from 2016 to 2027
-
1.3.4 USA Immunology Drug Market Size and Growth Rate of Immunosuppressive medication from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Immunology Drug Market Size and Growth Rate of Hospitals from 2016 to 2027
-
1.4.2 USA Immunology Drug Market Size and Growth Rate of Clinics from 2016 to 2027
-
1.4.3 USA Immunology Drug Market Size and Growth Rate of Cancer Research Centers and Institutes from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Immunology Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Immunology Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Immunology Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Immunology Drug Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Immunology Drug Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Immunology Drug by Major Types
-
3.4.1 Market Size and Growth Rate of Monoclonal Antibodies (mAb)
-
3.4.2 Market Size and Growth Rate of Antibody Drug Conjugates
-
3.4.3 Market Size and Growth Rate of Interferon and Cytokine therapies
-
3.4.4 Market Size and Growth Rate of Immunosuppressive medication
4 Segmentation of Immunology Drug Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Immunology Drug by Major End-Users
-
4.4.1 Market Size and Growth Rate of Immunology Drug in Hospitals
-
4.4.2 Market Size and Growth Rate of Immunology Drug in Clinics
-
4.4.3 Market Size and Growth Rate of Immunology Drug in Cancer Research Centers and Institutes
5 Market Analysis by Regions
-
5.1 USA Immunology Drug Production Analysis by Regions
-
5.2 USA Immunology Drug Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Immunology Drug Landscape Analysis
-
6.1 West USA Immunology Drug Landscape Analysis by Major Types
-
6.2 West USA Immunology Drug Landscape Analysis by Major End-Users
7 South USA Immunology Drug Landscape Analysis
-
7.1 South USA Immunology Drug Landscape Analysis by Major Types
-
7.2 South USA Immunology Drug Landscape Analysis by Major End-Users
8 Middle West USA Immunology Drug Landscape Analysis
-
8.1 Middle West USA Immunology Drug Landscape Analysis by Major Types
-
8.2 Middle West USA Immunology Drug Landscape Analysis by Major End-Users
9 Northeast USA Immunology Drug Landscape Analysis
-
9.1 Northeast USA Immunology Drug Landscape Analysis by Major Types
-
9.2 Northeast USA Immunology Drug Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Eli Lilly and Company
-
10.1.1 Eli Lilly and Company Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Active Biotech
-
10.2.1 Active Biotech Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Abbott Laboratories
-
10.3.1 Abbott Laboratories Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Bayer AG
-
10.4.1 Bayer AG Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 GlaxoSmithKline plc
-
10.5.1 GlaxoSmithKline plc Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Genentech
-
10.6.1 Genentech Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Pfizer
-
10.7.1 Pfizer Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 Seattle Genetics
-
10.8.1 Seattle Genetics Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Immunology Drug Market Size and Growth Rate of Monoclonal Antibodies (mAb) from 2016 to 2027
-
Figure USA Immunology Drug Market Size and Growth Rate of Antibody Drug Conjugates from 2016 to 2027
-
Figure USA Immunology Drug Market Size and Growth Rate of Interferon and Cytokine therapies from 2016 to 2027
-
Figure USA Immunology Drug Market Size and Growth Rate of Immunosuppressive medication from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Immunology Drug Market Size and Growth Rate of Hospitals from 2016 to 2027
-
Figure USA Immunology Drug Market Size and Growth Rate of Clinics from 2016 to 2027
-
Figure USA Immunology Drug Market Size and Growth Rate of Cancer Research Centers and Institutes from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Immunology Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Immunology Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Immunology Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Immunology Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Immunology Drug Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Immunology Drug
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Immunology Drug by Different Types from 2016 to 2027
-
Table Consumption Share of Immunology Drug by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Monoclonal Antibodies (mAb)
-
Figure Market Size and Growth Rate of Antibody Drug Conjugates
-
Figure Market Size and Growth Rate of Interferon and Cytokine therapies
-
Figure Market Size and Growth Rate of Immunosuppressive medication
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Immunology Drug by Different End-Users from 2016 to 2027
-
Table Consumption Share of Immunology Drug by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospitals
-
Figure Market Size and Growth Rate of Clinics
-
Figure Market Size and Growth Rate of Cancer Research Centers and Institutes
-
Table USA Immunology Drug Production by Regions
-
Table USA Immunology Drug Production Share by Regions
-
Figure USA Immunology Drug Production Share by Regions in 2016
-
Figure USA Immunology Drug Production Share by Regions in 2021
-
Figure USA Immunology Drug Production Share by Regions in 2027
-
Table USA Immunology Drug Consumption by Regions
-
Table USA Immunology Drug Consumption Share by Regions
-
Figure USA Immunology Drug Consumption Share by Regions in 2016
-
Figure USA Immunology Drug Consumption Share by Regions in 2021
-
Figure USA Immunology Drug Consumption Share by Regions in 2027
-
Table West USA Immunology Drug Consumption by Types from 2016 to 2027
-
Table West USA Immunology Drug Consumption Share by Types from 2016 to 2027
-
Figure West USA Immunology Drug Consumption Share by Types in 2016
-
Figure West USA Immunology Drug Consumption Share by Types in 2021
-
Figure West USA Immunology Drug Consumption Share by Types in 2027
-
Table West USA Immunology Drug Consumption by End-Users from 2016 to 2027
-
Table West USA Immunology Drug Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Immunology Drug Consumption Share by End-Users in 2016
-
Figure West USA Immunology Drug Consumption Share by End-Users in 2021
-
Figure West USA Immunology Drug Consumption Share by End-Users in 2027
-
Table South USA Immunology Drug Consumption by Types from 2016 to 2027
-
Table South USA Immunology Drug Consumption Share by Types from 2016 to 2027
-
Figure South USA Immunology Drug Consumption Share by Types in 2016
-
Figure South USA Immunology Drug Consumption Share by Types in 2021
-
Figure South USA Immunology Drug Consumption Share by Types in 2027
-
Table South USA Immunology Drug Consumption by End-Users from 2016 to 2027
-
Table South USA Immunology Drug Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Immunology Drug Consumption Share by End-Users in 2016
-
Figure South USA Immunology Drug Consumption Share by End-Users in 2021
-
Figure South USA Immunology Drug Consumption Share by End-Users in 2027
-
Table Middle West USA Immunology Drug Consumption by Types from 2016 to 2027
-
Table Middle West USA Immunology Drug Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Immunology Drug Consumption Share by Types in 2016
-
Figure Middle West USA Immunology Drug Consumption Share by Types in 2021
-
Figure Middle West USA Immunology Drug Consumption Share by Types in 2027
-
Table Middle West USA Immunology Drug Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Immunology Drug Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Immunology Drug Consumption Share by End-Users in 2016
-
Figure Middle West USA Immunology Drug Consumption Share by End-Users in 2021
-
Figure Middle West USA Immunology Drug Consumption Share by End-Users in 2027
-
Table Northeast USA Immunology Drug Consumption by Types from 2016 to 2027
-
Table Northeast USA Immunology Drug Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Immunology Drug Consumption Share by Types in 2016
-
Figure Northeast USA Immunology Drug Consumption Share by Types in 2021
-
Figure Northeast USA Immunology Drug Consumption Share by Types in 2027
-
Table Northeast USA Immunology Drug Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Immunology Drug Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Immunology Drug Consumption Share by End-Users in 2016
-
Figure Northeast USA Immunology Drug Consumption Share by End-Users in 2021
-
Figure Northeast USA Immunology Drug Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Eli Lilly and Company
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly and Company
-
Figure Sales and Growth Rate Analysis of Eli Lilly and Company
-
Figure Revenue and Market Share Analysis of Eli Lilly and Company
-
Table Product and Service Introduction of Eli Lilly and Company
-
Table Company Profile and Development Status of Active Biotech
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Active Biotech
-
Figure Sales and Growth Rate Analysis of Active Biotech
-
Figure Revenue and Market Share Analysis of Active Biotech
-
Table Product and Service Introduction of Active Biotech
-
Table Company Profile and Development Status of Abbott Laboratories
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbott Laboratories
-
Figure Sales and Growth Rate Analysis of Abbott Laboratories
-
Figure Revenue and Market Share Analysis of Abbott Laboratories
-
Table Product and Service Introduction of Abbott Laboratories
-
Table Company Profile and Development Status of Bayer AG
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer AG
-
Figure Sales and Growth Rate Analysis of Bayer AG
-
Figure Revenue and Market Share Analysis of Bayer AG
-
Table Product and Service Introduction of Bayer AG
-
Table Company Profile and Development Status of GlaxoSmithKline plc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline plc
-
Figure Sales and Growth Rate Analysis of GlaxoSmithKline plc
-
Figure Revenue and Market Share Analysis of GlaxoSmithKline plc
-
Table Product and Service Introduction of GlaxoSmithKline plc
-
Table Company Profile and Development Status of Genentech
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Genentech
-
Figure Sales and Growth Rate Analysis of Genentech
-
Figure Revenue and Market Share Analysis of Genentech
-
Table Product and Service Introduction of Genentech
-
Table Company Profile and Development Status of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-
Table Company Profile and Development Status of Seattle Genetics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Seattle Genetics
-
Figure Sales and Growth Rate Analysis of Seattle Genetics
-
Figure Revenue and Market Share Analysis of Seattle Genetics
-
Table Product and Service Introduction of Seattle Genetics
-
